Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Aspirin in the Secondary Prevention of Cardiovascular Disease

(2013) Anand K. Parekh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target

(2012) S. Pascale et al.   BLOOD

Primary and Secondary Prevention of Cardiovascular Disease

(2012) Per Olav Vandvik et al.   CHEST

Antiplatelet Therapy and Proton Pump Inhibition

(2012) George V. Moukarbel et al.   CIRCULATION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Suboptimal Inhibition of Platelet Cyclooxygenase-1 by Aspirin in Metabolic Syndrome

(2012) James P. Smith et al.   HYPERTENSION

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes

(2012) B. ROCCA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Meta-Analysis of Multiple Primary Prevention Trials of Cardiovascular Events Using Aspirin

(2011) Alfred A. Bartolucci et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease

(2011) Nina Raju et al.   AMERICAN JOURNAL OF MEDICINE

Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications

(2011) Luis A. García Rodríguez et al.   CIRCULATION

Antiplatelet agents for the treatment and prevention of atherothrombosis

(2011) Carlo Patrono et al.   EUROPEAN HEART JOURNAL

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

(2011) Marie-Germaine Bousser et al.   LANCET

Increased risk of stroke after discontinuation of acetylsalicylic acid: A UK primary care study

(2011) L. A. Garcia Rodriguez et al.   NEUROLOGY

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

(2010) Michael Pignone et al.   CIRCULATION

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial

(2010) F. Gerald R. Fowkes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

(2009) A. Dragani et al.   BLOOD

Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays

(2009) Francesca Santilli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Antiplatelet Drugs

(2008) Carlo Patrono et al.   CHEST

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

(2008) Gregory W. Albers et al.   CHEST

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Acetylation of prostaglandin H2 synthases by aspirin is inhibited by redox cycling of the peroxidase

(2007) Manju Bala et al.   BIOCHEMICAL PHARMACOLOGY

Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas

(2007) Richard F.A. Logan et al.   GASTROENTEROLOGY